FOR IMMEDIATE RELEASE:
Industry leaders join to offer market access solutions for biopharmaceuticals, biotechnology, and medical devices across Asia-Pacific markets
Singapore (April 14, 2010) – Clearstate Pte. Ltd. and United BioSource Corporation (UBC) today announced a strategic partnership to provide global market access, pricing and reimbursement strategies for manufacturers of biopharmaceuticals, medical devices, and other medical technology.
The agreement reinforces Clearstate’s position as the premier source for accurate and actionable market intelligence across the Asia-Pacific region and builds upon UBC’s leadership in delivering global market access strategies for life science products. The alliance provides UBC and its clients with reliable access to the highest quality market access, pricing and reimbursement information.
“UBC offers many of the industry’s leading scientific and industry experts and a unique portfolio of capabilities to support the worldwide development and commercialization of biopharmaceuticals, medical devices, and other medical technology,” said Tej Deol M.D., Clearstate’s Managing Partner. “This, agreement underscores our desire to build collaborative strategic relationships with global firms capable of providing the highest quality health care advisory services. Our relationship with UBC demonstrates our shared commitment to provide clients with the most accurate and comprehensive market intelligence for markets in the Asia Pacific region,”
“We are extremely pleased to partner with Clearstate to offer comprehensive market access strategies throughout the Asia-Pacific region,” said Lisbet Coulton, Director of International Pricing and Reimbursement at UBC. “As life science companies expand their operations throughout the Asia-Pacific region, UBC and Clearstate are ideally positioned to support their products. Our clients have been delighted with the insight and expertise provided by Clearstate and we believe our partnership offers significant value for companies seeking effective market access solutions in this region.”
About Clearstate Pte. Ltd.
Founded in 2006 and headquartered in Singapore, Clearstate is a market intelligence firm committed to the Healthcare and Life Science domains specifically within the Asia Pacific region. We offer strategic advisory and customized primary research solutions to help medical devices, healthcare services, pharmaceutical and biotechnology firms understand their current and potential markets, and implement pragmatic and innovative strategies to ultimately tap into new growth opportunities within these opaque and challenging markets. For more information about Clearstate, visit its website at www.clearstate.com.
About United BioSource Corporation
United BioSource Corporation (UBC) is a global scientific and medical affairs organization that partners with life science companies to develop and commercialize biopharmaceuticals, medical devices, and other health care technologies. We help deliver authoritative, real-world evidence to characterize product effectiveness, address safety risk, and demonstrate value. UBC brings together recognized scientific and industry experts, research operations professionals, and new technologies to provide innovative solutions across the product lifecycle. The company is headquartered in Bethesda, Maryland, with offices in North and South America, Europe and Asia. For more information about UBC, visit www.unitedbiosource.com.
For more information please email us at:
info@clearstate.com
info@unitedbiosource.com